Determination of left ventricular mass and circumferential wall thickness by three-dimensional reconstruction: in vitro validation of a new method that uses a multiplane transesophageal transducer.

Elevated left ventricular mass and increased wall thickness have important prognostic implications in clinical medicine. However, these parameters have been incompletely characterized by one- and two-dimensional echocardiography. Therefore this study was performed to validate in vitro measurement of left ventricular mass and circumferential wall thickness with a multiplane transesophageal transducer and three-dimensional reconstruction. Results for mass measurements were also compared with a standard method for the determination of left ventricular mass, the Penn convention. Fourteen necropsied left ventricles were scanned in a water bath by a volume-rendering, three-dimensional reconstruction system. There was an excellent correlation and high agreement for determination of three-dimensional left ventricular mass (r = 0.98; standard error of the estimate [SEE] = 9.6 gm; y = 1.02x + 0.46) and wall thickness (r = 0.93; SEE = 1.4 mm; y = 0.95x + 1.64) compared with anatomic measurements. Left ventricular mass by a simulated Penn convention revealed a lower correlation and larger error compared with three-dimensional measurements (r = 0.72; SEE = 42.8 gm; y = 1.01x + 9.61). Therefore determination of left ventricular mass by three-dimensional reconstruction was validated in vitro and was superior to one-dimensional echocardiographic methods.

[1]  D. King,et al.  Three-dimensional echocardiographic measurement of left ventricular volume in vitro: comparison with two-dimensional echocardiography and cineventriculography. , 1993, Journal of the American College of Cardiology.

[2]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[3]  R A Levine,et al.  Quantitative three-dimensional reconstruction of aneurysmal left ventricles. In vitro and in vivo validation. , 1995, Circulation.

[4]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[6]  J. Gottdiener,et al.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. , 1981, The American journal of cardiology.

[7]  A. DeMaria,et al.  Comparison of two- and three-dimensional echocardiography with cineventriculography for measurement of left ventricular volume in patients. , 1994, Journal of the American College of Cardiology.

[8]  R. Devereux,et al.  Evaluation of left ventricular hypertrophy by M-mode echocardiography in patients and experimental animals. , 1994, American journal of cardiac imaging.

[9]  J. Roelandt,et al.  Ultrasonic dynamic three-dimensional visualization of the heart with a multiplane transesophageal imaging transducer. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  F. Flachskampf,et al.  Initial experience with a multiplane transoesophageal echo-transducer: assessment of diagnostic potential. , 1992, European heart journal.

[11]  A. Bouchard,et al.  Left ventricular mass and volume/mass ratio determined by two-dimensional echocardiography in normal adults. , 1985, Journal of the American College of Cardiology.

[12]  H Wollschläger,et al.  Three‐Dimensional and Four‐Dimensional Transesophageal Echocardiographic Imaging of the Heart and Aorta in Humans Using a Computed Tomographic Imaging Probe , 1992, Echocardiography.

[13]  D. King,et al.  Three-dimensional echocardiographic volume computation: in vitro comparison to standard two-dimensional echocardiography. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  L M Boxt,et al.  Three-dimensional echocardiographic volume computation by polyhedral surface reconstruction: in vitro validation and comparison to magnetic resonance imaging. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[15]  J. Laragh,et al.  Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. , 1986, Annals of internal medicine.

[16]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[17]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[18]  E. Salcedo,et al.  Left ventricular mass and wall thickness in hypertension. Comparison of M mode and two dimensional echocardiography in two experimental models. , 1979, The American journal of cardiology.

[19]  F. Flachskampf,et al.  Three-dimensional reconstruction of cardiac structures from transesophageal echocardiography. , 1995, American journal of cardiac imaging.

[20]  J. Hestenes,et al.  Cross‐sectional Echocardiography 1. Analysis of Mathematic Models for Quantifying Mass of the Left Ventricle in Dogs , 1979, Circulation.

[21]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[22]  D. Levy,et al.  Prognosis of left ventricular geometric patterns in the Framingham Heart Study. , 1995, Journal of the American College of Cardiology.

[23]  J. Rivera,et al.  Three-dimensional reconstruction of ventricular septal defects: validation studies and in vivo feasibility. , 1994, Journal of the American College of Cardiology.

[24]  D. King,et al.  Three-dimensional echocardiography: in vitro and in vivo validation of left ventricular mass and comparison with conventional echocardiographic methods. , 1994, Journal of the American College of Cardiology.

[25]  M. Kronenberg,et al.  Reproducibility of left ventricular mass measurements by two-dimensional and M-mode echocardiography. , 1989, Journal of the American College of Cardiology.

[26]  D. King,et al.  Assessment of cardiac function by three-dimensional echocardiography compared with conventional noninvasive methods. , 1995, Circulation.

[27]  N. Reichek,et al.  Anatomic Validation of Left Ventricular Mass Estimates from Clinical Two‐dimensional Echocardiography: Initial Results , 1983, Circulation.

[28]  M. Lipton,et al.  Canine left ventricular mass estimation by two-dimensional echocardiography. , 1983, Circulation.

[29]  N Reichek,et al.  Quantitation of Human Left Ventricular Mass and Volume by Two‐dimensional Echocardiography: In Vitro Anatomic Validation , 1981, Circulation.

[30]  J. Rivera,et al.  Quantification of pericardial effusions by three-dimensional echocardiography. , 1994, Journal of the American College of Cardiology.

[31]  E. Corday,et al.  Assessment of quantitative methods for 2-dimensional echocardiography. , 1983, The American journal of cardiology.

[32]  D. King,et al.  Left ventricular volume and endocardial surface area by three-dimensional echocardiography: comparison with two-dimensional echocardiography and nuclear magnetic resonance imaging in normal subjects. , 1993, Journal of the American College of Cardiology.

[33]  R A Levine,et al.  Three-dimensional echocardiographic reconstruction of right ventricular volume: in vitro comparison with two-dimensional methods. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[34]  R A Levine,et al.  Three-dimensional echocardiography: in vivo validation for right ventricular free wall mass as an index of hypertrophy. , 1994, Journal of the American College of Cardiology.

[35]  D. King,et al.  Three-dimensional echocardiography: in vitro validation for quantitative measurement of total and "infarct" surface area. , 1993, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[36]  J. Ghali,et al.  Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. , 1990, The American journal of cardiology.

[37]  J. Laragh,et al.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. , 1991, Annals of internal medicine.

[38]  C. Rackley,et al.  Measurement of Left Ventricular Wall Thickness and Mass by Echocardiography , 1972, Circulation.

[39]  G. Reboldi,et al.  Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. , 1995, Journal of the American College of Cardiology.

[40]  R A Levine,et al.  A New Integrated System for Three-Dimensional Echocardiographic Reconstruction: Development and Validation for Ventricular Volume with Application in Human Subjects , 1993, Journal of the American College of Cardiology.

[41]  D. Levy,et al.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. , 1989, Annals of internal medicine.

[42]  R A Levine,et al.  Three-dimensional echocardiography. In vivo validation for right ventricular volume and function. , 1993, Circulation.

[43]  R S Meltzer,et al.  Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements. , 1983, Journal of the American College of Cardiology.

[44]  A. Sniderman,et al.  Impact of left ventricular hypertrophy on survival in end-stage renal disease. , 1989, Kidney international.

[45]  J. Gottdiener,et al.  Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. , 1995, Journal of the American College of Cardiology.